Pfizer Could Hit $36 by Year-End as Analysts See 2-to-1 Payoff on Key Prostate Cancer Trial
Corroborated by 1 source from 1 publisher
globalcrime2h ago
TL;DR
According to finance.yahoo.com, quick Read - - - Have You read The New Report Shaking Up Retirement Plans.